Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)

BACKGROUND: For patients with locally advanced (T3-4/N +) rectal cancer (LARC), the standard treatment is neoadjuvant chemoradiotherapy combined with total mesorectal resection, which greatly decreases local recurrence but does not improve overall survival. For patients who achieve a complete clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaqi, Shen, Lijun, Wan, Juefeng, Zhang, Hui, Wu, Ruiyan, Wang, Jingwen, Wang, Yan, Xu, Ye, Cai, Sanjun, Zhang, Zhen, Xia, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922781/
https://www.ncbi.nlm.nih.gov/pubmed/35291966
http://dx.doi.org/10.1186/s12885-022-09348-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922781/
https://www.ncbi.nlm.nih.gov/pubmed/35291966
http://dx.doi.org/10.1186/s12885-022-09348-z

Ejemplares similares